check_circleStudy Completed

Contraception, Ovulation Inhibition, Contraceptives, Oral

Study to evaluate the ovulation inhibitory effect of Minisiston® (0.03 mg Ethinylestradiol and 0.125 mg Levonorgestrel)

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
32
Trial Dates
March 2003 - July 2003
Phase
Phase 4
Could I Receive a placebo
N/A
Products
Minisiston/Monostep (EE30/LNG, BAY86-4977)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

Monocenter, open-label, uncontrolled study to evaluate the ovulation inhibitory effect of Minisiston® (0.03 mg Ethinyl estradiol and 0.125 mg Levonorgestrel), applied for two treatment cycles to 30 female volunteers
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A